The market for cardiac and diabetes drugs has tripled in the past five years, according to a recent report. The increase in demand for these medications highlights the growing prevalence of heart disease and diabetes worldwide. The Financial Express reported on this significant growth in the pharmaceutical industry, as more people are seeking treatment for these chronic conditions. This trend indicates the need for continued research and development in the field of cardiovascular and diabetes medications to meet the rising demand. The report serves as a reminder of the importance of investing in healthcare to address the increasing burden of these diseases on global public health.